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Abstract
Background: At present, dementia has no known cure. Interventions to delay onset and reduce prevalence of the
disease are therefore focused on risk factor reduction. Previous population attributable risk estimates for western
countries may have been underestimated as a result of the relatively low rates of midlife obesity and the lower
weighting given to that variable in statistical models.
Methods: Levin’s Attributable Risk which assumes independence of risk factors was used to calculate the
proportion of dementia attributable to seven modifiable risk factors (midlife obesity, physical inactivity, smoking,
low educational attainment, diabetes mellitus, midlife hypertension and depression) in Australia. Using a recently
published modified formula and survey data from the Australia Diabetes, Obesity and Lifestyle Study, a more
realistic population attributable risk estimate which accounts for non-independence of risk factors was calculated.
Finally, the effect of a 5–20% reduction in each risk factor per decade on future dementia prevalence was
computed.
Results: Taking into consideration that risk factors do not operate independently, a more conservative estimate of
48.4% of dementia cases (117,294 of 242,500 cases) was found to be attributable to the seven modifiable lifestyle
factors under study. We calculated that if each risk factor was to be reduced by 5%, 10%, 15% and 20% per decade,
dementia prevalence would be reduced by between 1.6 and 7.2% in 2020, 3.3–14.9% in 2030, 4.9–22.8% in 2040
and 6.6–30.7% in 2050.
Conclusion: Our largely theory-based findings suggest a strong case for greater investment in risk factor reduction
programmes that target modifiable lifestyle factors, particularly increased engagement in physical activity. However,
further data on risk factor treatment and dementia risk reduction from population-based studies are needed to
investigate whether our estimates of potential dementia prevention are indeed realistic.
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Background
Dementia describes a collection of symptoms associated
with impaired memory and is characterised by progres-
sive declines in thinking ability, physical function and
behaviour [1]. Dementia has no known cure, and as it
progresses so too does the inability to perform tasks of
daily living [2]. At present, more than 40 million people
worldwide are estimated to have the condition, with over
US$600 billion spent on treatment and management [3,
4]. This figure is projected to increase to well over 70
million people by 2030 [4]. Such worrying future preva-
lence estimates highlight the need for urgent interven-
tion focused on risk reduction because even a modest
delay in onset can result in significant public health
gains.
Cognitive decline and dementia are multi-causal. Re-
search has shown that lifestyle factors (e.g. smoking
habits, diet and physical inactivity) increase the risk of
late-life dementia and that interventions targeting these
can significantly reduce the population prevalence of
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dementia [5–7]. The potential impact of possible inter-
ventions to delay the onset of dementia on future preva-
lence of the condition has been reported previously for
the world and specific regions [8, 9]. It is estimated that
any intervention which could delay the onset of demen-
tia by 1 year could reduce worldwide cases by 11% [10],
while a 2-year and 5-year delay in onset could reduce
the cumulative number of people developing dementia
by 13% and 30% respectively [8]. In Australia, published
research highlights that as little as a 10% reduction in
dementia cases attributable to key modifiable lifestyle
factors could result in savings of $280 million [11].
Delaying dementia onset therefore not only lessens the
average number of years spent living with the disease
but also has significant public health resource allocation
implications [12].
Using a method published previously [9], we estimated
the proportion of dementia in the Australian setting at-
tributable to seven modifiable risk factors shown to be
associated with the disease in the literature (midlife
obesity, physical inactivity, smoking, low educational at-
tainment, diabetes mellitus, midlife hypertension and
depression).
Our study is novel because we take into account non-
independence of risk factors, thereby providing more
realistic population attributable risk (PAR) estimates for
Australia than those obtained using the traditional Levin
formula. In addition, we aimed to examine the effect of
reducing the relative prevalence of each risk factor by
5%, 10%, 15% and 20% per decade (compounding reduc-
tions) on the future prevalence of dementia. Finally, we
wanted to compare our PAR estimates with those pro-
duced previously for the USA, the UK, Europe and
Australia.
To the authors’ knowledge, this is the only Australian
study to provide estimates of PARs and future dementia
prevalence taking into consideration non-independence
of risk factors and utilising such a wide range of modifi-
able risk factors. This work will allow for comparison of
Australia with other countries and other regions, and
will inform dementia risk reduction policies.
Method
PAR allows researchers and policymakers to estimate
how much disease could be eliminated if there was a re-
duction in the prevalence of a causal factor or groups of
interrelated factors [13]. For the calculation of PAR, rela-
tive risk and disease prevalence data are needed [14]. In
the present study, the population prevalence of each risk
factor was obtained from the 2011–2013 Australian
Health Survey (the largest and most comprehensive
health survey ever conducted in Australia) [15]. This
survey represents a collation of the National Health Sur-
vey (n = 20,500 persons; one adult and one child from
15,500 households), the National Aboriginal and Torres
Strait Islander Health Survey (n = 13,000), the National
Nutrition and Physical Activity Survey (n = 12,000 per-
sons; one adult and one child from 9500 households)
and a National Health Measures Survey (11,000 survey
participants aged 5+ years). The survey utilised a range
of data collection methods including questionnaires,
blood and urine tests and pedometers, and aimed to col-
lect information about health status, risk factors, socio-
economic circumstances, health-related actions, nutri-
tion, physical activity and use of medical services. Table 1
presents the definitions for each of the risk factors in-
cluded in the study.
Meta-analyses examining the association between de-
mentia and the seven risk factors of interest were used
to obtain relative risk data. Table 2 presents the relative
risk and prevalence data utilised in this study and their
sources.
Statistical analysis
Levin’s Population Attributable Risk formula was used to
calculate the proportion of dementia cases attributable
to each of the risk factors under investigation [16]:
PAR ¼ P  RR − 1ð Þ= 1þ P  RR − 1ð ð Þ½
where P = population prevalence and RR = relative risk.
Still assuming independence of risk factors, we esti-
mated their combined effect [17]:
Combined PAR ¼ 1 − 1 − PARmidlife obesity
 
 1 − PAR physical inactivity
  1 − PARsmoking
 
 1 − PARlow education attainmentð Þ
 1 − PARdiabetes mellitusð Þ
 1 − PARmidlife hypertension
  1 − PARdepression
 
We accounted for non-independence of risk factors by
using a previously published modified formula which
takes into account the unique contribution of each risk
factor ‘w’ [9]:
PARAdjusted Combined ¼ 1 − Π1 − w  PARð Þ:
Factor analysis was used to estimate communality for
each risk factor using data for adults aged 25 years and
older from the Australia Diabetes, Obesity and Lifestyle
Study—Wave 3 (AusDiab). The AusDiab is a
population-based national survey of the general (non-
institutionalised) Australian population aged 25 years
and older.
The total number of dementia cases related to each of
the seven risk factors was calculated as the product of
their individual PARs and dementia prevalence.
The effect of reducing the relative prevalence of each
risk factor by 5%, 10%, 15% or 20% per decade on the
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future prevalence of dementia in Australia was calcu-
lated using published dementia prevalence estimates for
Australia [18, 19].
Results
Table 3 presents the results of PAR calculations taking
into consideration both independence and non-
independence of risk factors. Confidence limits for PAR
and the number of attributable cases were calculated
using a published substitution method [20].
Assuming independence of risk factors, we esti-
mated that the seven risk factors examined contribute
up to 57.0% of dementia cases in Australia. In order
to account for interaction between risk factors, data
for those aged 25 years and older from the AusDiab
were used to estimate the shared variance for all
seven risk factors (presented in Table 2). More specif-
ically, to obtain communality we used STATA version
12 to generate a matrix of tetrachoric correlations
and subsequently performed exploratory factor ana-
lysis using the correlation matrix as input. Similar to
other studies, we used the Kaiser criterion for
selecting the number of factors to retain [9]. Ac-
counting for non-independence of risk factors, we es-
timated that the seven risk factors contributed 48.4%
of dementia cases in Australia.
Effect of risk factor reduction
Table 4 and Fig. 1 show the effect of a 5%, 10%, 15% and
20% per decade reduction in each risk factor on future
dementia prevalence estimates.
Discussion
Assuming independence of risk factors, 57.0% of demen-
tia cases in Australia could be related to the seven modi-
fiable risk factors under study. Taking into consideration
the non-independence of risk factors, we estimated that
approximately 48.4% of dementia cases could be attrib-
uted to these risk factors. A reduction of between 5 and
20% per decade would have the effect of reducing future
dementia prevalence by between 1.6 and 30.7% from
2020 to 2050. Our findings show that the percentage of
cases explained by the risk factors under study is higher
than that explained by APOE e4 (the main risk factor
Table 1 Risk factor definitions
Risk factor Definition
Mid-life obesity The proportion of adults (45–54 years) with BMI≥ 30 (based on measured height and weight)
Physical inactivity The proportion of adults not meeting physical activity guidelines based on self-reported physical activity engagement in the
past 7 days and pedometer data (150–300 minutes of moderate intensity physical activity or 75–150 minutes of vigorous in-
tensity physical activity, or an equivalent combination of both moderate and vigorous activities, each week)
Smoking The proportion of adult smokers (based on self-report data)
Low educational
attainment
The proportion of adults who have a primary and/or secondary school education (based on self-report data)
Diabetes mellitus The prevalence of diagnosed diabetes mellitus among adults (based on self-report and biomedical data)
Midlife hypertension The prevalence of hypertension in adults (aged 45–54 years) (based on self-report data)
Depression Lifetime prevalence estimates of major depression using Diagnostic and Statistical Manual of Mental Disorders or
International Classification of Diseases criteria (based on questionnaire data including diagnostic interviews and
psychological distress scales)
Table 2 Prevalence and relative risk data sources
Risk factor Prevalence Relative risk Communality (%)a
Midlife obesity 32.0b 1.64 (1.34–2.00)d 28.9
Physical inactivity 56.0b 1.39 (1.16–1.67)e 16.9
Smoking 16.1b 1.28 (0.99–1.60)d 11.3
Low educational attainment 24.0b 1.72 (1.52–1.96)d 12.9
Diabetes mellitus 5.4b 1.46 (1.20–1.77)d 30.6
Midlife hypertension 26.0b 1.61 (1.16–2.24)f 31.5
Depression 13.3c 1.65 (1.42–1.92)d 4.2
a Estimated using the Australia Diabetes, Obesity and Lifestyle Study 2012 [32]
b Obtained from ABS Health Survey 2012–2013 [29]
c Obtained from AIHW, 2007 [30]
d World Alzheimer Report, 2014 [21]
e Obtained from Hamer et al., 2009 [31]
f Obtained from Norton et al., 2014 [14]
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for AD). This highlights the importance of targeting
modifiable risk factors in dementia reduction policies
and programmes.
Similar to a previously published study which utilised
data from the USA, Europe and the UK [14], we found
that physical inactivity was related to the largest propor-
tion of dementia cases. PAR estimates from our study
and those published for the USA, Europe and the UK
can also be compared because both studies examined
midlife obesity, physical inactivity, smoking, low educa-
tional attainment, diabetes mellitus and midlife hyper-
tension [9]. Although reported for AD cases, the authors
of the international study suggest that their PAR esti-
mates can be applied to the most common forms of de-
mentia [9]. Overall, midlife obesity is related to a greater
proportion of dementia cases in Australia (17.0%) than
in the USA (7.3%), Europe (4.1%) and the UK (6.6%) [9],
while physical inactivity is related to a relatively smaller
proportion of cases in Australia (17.9%) than in the USA
(21.0%), Europe (20.3%) and the UK (21.8%). Notably, a
smaller proportion of dementia cases is attributable to
smoking in Australia (8.7%) when compared with the
USA (10.8%), Europe (13.6%) and the UK (10.6%). The
proportion of dementia cases attributable to low educa-
tional attainment in the USA (7.3%), the UK (12.2%) and
Europe (13.6%) is lower than that of Australia (14.7%).
Our PAR estimate for diabetes mellitus is lower than
those recorded for USA (4.5%) and Europe (3.1%) but
higher than the UK estimate (1.9%). These differences
may be predominantly due to the prevalence of these in-
dividual risk factors in each country and also to varia-
tions in risk factor definitions used between studies. For
example, the midlife obesity prevalence for the USA uti-
lised in Norton et al.’s study (13.1%) [14] is lower than
our Australian estimate (32.0%) and also lower than the
US Centers for Disease Control’s 2015 estimate (40.2%)
[2]. The contribution of this risk factor to dementia
prevalence is therefore likely to be significantly higher
than calculated and more in line with our Australian
PAR estimate. In addition, our estimate for low educa-
tional attainment may be higher than that published for
other countries because our definition included all those
who had a primary and/or secondary school education
only (i.e. up to Year 12). Prior studies have used a less
inclusive definition for low education (i.e. up to lower
secondary schooling). We noted that the small difference
between the analysis assuming independence and ac-
counting for non-independence in our study (57.0% vs
48.4%) is in contrast to those published for the USA
(52.7% vs 30.6%), Europe (54.0% vs 31.4%) and the UK
(52.0% vs 30.0%). While we are unable to fully account
for this observed difference, one possible explanation
Table 3 PAR of dementia for each risk factor and number of cases attributable in 2010
Risk factor Prevalence of risk factor PAR % (95% CI) Number of attributable cases in 2010 (95% CI)
Midlife obesity 32.0 17.0 (9.8–24.2) 41,222 (23,795–58,788)
Physical inactivity 56.0 17.9 (8.2–27.3) 43,468 (19,941–66,162)
Smoking 16.1 4.3 (–0.2 to 8.8) 10,460 (–391 to 21,362)
Low educational attainment 24.0 14.7 (11.1–18.7) 35,730 (26,906–45,410)
Diabetes mellitus 5.4 2.4 (1.1–4.0) 5878 (2591–9681)
Midlife hypertension 26.0 13.7 (4.0–24.4) 33,196 (9685–59,121)
Depression 13.3 8.0 (5.3–10.9) 19,296 (12,829–26,437)
Combined – 57.0 (33.7–73.6) 138,020 (81,716–178,454)
Adjusted combined – 48.4 (28.1–64.2) 117,294 (68,233–155,634)
Dementia cases 2010 = 242,500 [33]
CI confidence interval, PAR population attributable risk
Table 4 Effect of a 5%, 10%, 15% and 20% per decade reduction in each risk factor on future dementia prevalence (2010–2050)
Dementia estimate
Reduction per decade 2010 2020 2030 2040 2050
242,500 384,396 553,285 760,131 942,624
5% 242,500 (0.0%) 378,293
(1.6%)
535,831
(3.3%)
724,417
(4.9%)
884,021
(6.6%)
10% 242,500
(0.0%)
371,946
(3.3%)
517,987
(6.8%)
688,631
(10.4%)
826,632
(14.0%)
15% 242,500
(0.0%)
365,346
(5.2%)
499,850
(10.7%)
653,296
(16.4%)
771,870
(22.1%)
20% 242,500
(0.0%)
358,477
(7.2%)
481,528
(14.9%)
618,937
(22.8%)
720,965
(30.7%)
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may be that it could be due to the effect of the com-
puted weight ‘w’, which represents the proportion of the
variance shared with other risk factors and which was
comparatively higher in our study for all variables. While
the assumptions on which the models for the UK, the
USA and Australia are based are the same, the compara-
tively high ‘w’ value in Australia indicates that commu-
nality is low among risk factors and is suggestive of low
co-morbidity among the risk factors under study. Fur-
ther analysis of the primary dataset employed would
need to be conducted in order to elucidate the exact
cause of this disparity. It should, however, be acknowl-
edged that low co-morbidity may be a result of various
policy measures such as tobacco control efforts. Another
important factor to be taken into account is the compet-
ing risk of death as a result of increased age and co-
morbidities of older participants.
Our study builds on the methodology used in a recent
Alzheimer’s Australia report based on 2014 ABS popula-
tion projection data [11]. This report calculates PAR es-
timates assuming that risk factors operate
independently. Here, we have accounted for non-
independence of risk factors using a population-based
sample and utilised compounding reductions each dec-
ade in order to determine the effect on future prevalence
of disease. In both studies, however, physical activity ex-
plained the greatest proportion of dementia cases in the
sample (24.8% and 17.9% respectively) [11]. A closer
comparison reveals that the prior published estimates
were higher for all commonly examined risk factors ex-
cept midlife obesity, low education attainment and dia-
betes mellitus (midlife obesity: 13.9% vs 17.0%, physical
inactivity: 24.8% vs 17.9%, smoking: 9.4% vs 4.3%, low
educational attainment: 7.3% vs 14.7%, diabetes mellitus:
1.9% vs 2.4%, midlife hypertension: 16.3% vs 13.7% and
depression: 8.9% vs 8.0%) [11]. These differences may be
due to different sources of risk factor prevalence data
and behaviour modification, for example smoking cessa-
tion. We were, however, unable to compare the com-
bined effect of all examined risk factors because our
study was the only one to take these into account.
Most of the effect size estimates used for relative risk
in our study differ from those used in previous publica-
tions [9, 11]. While it would have been useful to utilise
relative risks from Australian cohort studies, such data
were not readily available for the risk factors being ex-
amined. As such, our relative risk estimates are taken
from the World Alzheimer Report 2014 which included
more recently published data [21]. The estimates used
were lower for smoking and physical inactivity in our
study but higher for midlife obesity and low educational
attainment. Sensitivity analysis conducted using the rela-
tive risks used in Norton et al.’s study show that the pro-
portions of dementia explained by midlife obesity
(16.1%) and physical inactivity (31.5%) were higher in
Australia than in the USA, Europe and the UK while
that of smoking was lower (8.7%) (see Additional file 1).
The Australian contribution of low educational attain-
ment (12.4%) was higher than the USA and UK esti-
mates but lower than that in Europe. PAR estimates for
diabetes mellitus, midlife hypertension and depression
remained unchanged because the same relative risks
were used in both studies. Overall, both combined PAR
and adjusted combined PAR were higher for our study
when the relative risk estimates used in previous studies
were utilised (Combined PAR:57.0% vs 64.3% and Ad-
justed Combined PAR: 48.4% vs 55.7% respectively).
Dementia may be delayed or prevented by targeting
modifiable lifestyle factors [11, 22]. For example, Access
Economics estimated that a 5-year delay in Alzheimer’s
disease (the most common form of dementia) onset
from 2005 would decrease prevalence by 48.5% in
Fig. 1 Percentage change in dementia cases as a result of a 5%, 10%, 15% and 20% reduction in each risk factor per decade. Estimated reduction
in dementia prevalence that could result from a 5–20% per decade reduction in the prevalence of the risk factors under study
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2040 [12]. Other studies have calculated that any inter-
vention which could delay onset by 5 years could de-
crease prevalence by between 37.0 and 44.0% [23, 24].
These projection estimates are higher than those re-
ported in our study and notably do not take into account
the dynamic interplay between risk factors which have
been considered in our study. Although imprecise, our es-
timates are more realistic and conservative.
The modifiable lifestyle factors considered in our study
have also been recognised as risk factors for developing
other conditions such as cardiovascular disease and cer-
tain cancers, all of which are leading causes of death in
Australia [25]. Our findings present a strong case for
greater investment in lifestyle interventions in preventing
dementia because these have the potential to reap other
health and well-being benefits as well. Reducing the preva-
lence of or delaying the onset of dementia has the poten-
tial to lessen the impact of the disease, both financially
and on individuals [26]. Delaying dementia onset lessens
the average number of years spent living with the disease
[12]. Those living with dementia for longer periods tend
to require considerably more health services per annum
than newly diagnosed individuals and this has substantial
public health resource allocation implications [12].
Because physical inactivity was shown to contribute to
the greatest proportion of dementia cases, this suggests
that targeted interventions aimed at those who are not
meeting recommendations may have the effect of redu-
cing dementia prevalence. Policymakers, however, must
be cognisant of the fact that no singular government
intervention/policy, operating on its own, can directly
reduce dementia onset/prevalence and change lifestyle
habits [27]. Further research is needed to examine the
monetary investment and time needed to reduce risk
factor prevalence (especially physical inactivity preva-
lence) to a level that will result in significant improve-
ment in the overall prevalence of dementia and other
chronic diseases. It is also worth noting that while de-
mentia risk reduction has the effect of increasing longev-
ity and delaying onset of disease, it may not necessarily
prevent the disease. Previous research has pointed to the
longevity paradox—age is the strongest predictor of dis-
eases that affect cognition and risk reduction has the po-
tential to increase life expectancy [28].
To the authors’ knowledge, this is the only Austra-
lian study to provide estimates of population attribut-
able risks (PARs) and future dementia prevalence
taking into consideration non-independence of risk
factors. This is also the only the Australian study to
examine the contribution of such a wide range of
modifiable risk factors. The methodology utilised in
this article has only been reported on once in the lit-
erature and represents a notable addition to the trad-
itional Levin formula used to calculate PAR in order
to account for non-independence of risk factors [9].
In our calculations, we have utilised the most recent
effect size estimates and have used a more realistic
estimate of midlife obesity than other published work
[14]. Our study therefore makes a valuable contribu-
tion to the research.
Limitations of using this method have been presented
in a previous study [9]. These include use of biased ad-
justed relative risk estimates obtained from meta-
analyses and the integrity of the method being untested
[9]. However, although the methodology is still new, it is
thought to provide a more realistic estimate of PAR. As
further studies are conducted using this adjusted PAR
calculation, there will be the opportunity to compare re-
sults across various geographic locations and test robust-
ness. In interpreting our results, we indicate that it is
beyond the scope of this study to prove that dementia
can be prevented or that such major reductions in
prevalence (up to 30.7%) are indeed possible. Further,
the effects of risk factor reduction programmes depend
on the stage of the lifecycle they are aimed to target, and
many of our included risk factors focus on midlife. Fur-
ther, there is a dynamic interplay among risk factors
throughout the life course. In addition, it is possible that
our figures overestimate the potential gain of risk reduc-
tion because they do not take into account that risk re-
duction leads to increased longevity which itself is a risk
factor for dementia [28]. We are cognisant of our use of
a relatively modest method and have considered utilising
more informative models that examine the most likely
future scenarios in our further work which take into ac-
count that each of the risk factors may be on a different
trajectory. For example, educational attainment and
smoking are both improving, while the prevalence of
diabetes and obesity are increasing. Thus, improvements
from the ‘base case’ are likely to be different for each risk
factor. Further, as noted in a prior study, our analyses re-
port on association between risk factors and disease and
do not attempt to determine causality—the real link be-
tween the risk factors examined and dementia may be
accounted for by other risk factors. Finally, while a sub-
stantial proportion of dementia cases was found to be at-
tributable to the risk factors under study, we did not
examine the contribution of other risk factors that have
been examined in the literature for dementia such as
fruit, vegetable, meat, fish and omega-3 intake and mid-
life serum cholesterol. Further studies are needed that
take these into consideration. In addition, there is a need
for more research into the effect of risk factor reduction
on dementia from population-based studies in order to
examine more nuanced issues such as effect size at vari-
ous stages in the lifecycle and the costs and specific ac-
tions needed to have the greatest public health impact.
Such data will no doubt prove useful to policymakers.
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Conclusion
Assuming that risk factors do not operate independently,
approximately 48.4% of dementia cases in Australia can
be potentially attributed to midlife obesity, physical in-
activity, smoking and low educational attainment. Any
intervention that reduces the prevalence of these by 5%,
10%, 15% or 20% per decade can have a significant public
health impact, especially with regards to lowering the dir-
ect and indirect costs incurred by both governments and
those living with the disease. Further research is needed
which aims to provide policymakers with a set plan of ac-
tion for achieving dementia risk reduction goals.
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